Tocilizumab-induced Leukoencephalopathy with a Reversible Clinical Course

Tocilizumab (TCZ; Actemra/RoActemra) is an anti-interleukin (IL)-6 receptor antibody for the treatment of rheumatoid arthritis (RA) and other autoimmune diseases and cytokine storms. The present case is a 63-year-old female well-controlled RA patient, who presented with a progressive cognitive impai...

Full description

Saved in:
Bibliographic Details
Published in:Intern Med
Main Authors: Sasaki, Ryo, Hishikawa, Nozomi, Nomura, Emi, Omote, Yoshio, Takemoto, Mami, Yamashita, Toru, Hatanaka, Noriko, Higashi, Yasuto, Abe, Koji
Format: Artigo
Language:Inglês
Published: The Japanese Society of Internal Medicine 2020
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725625/
https://ncbi.nlm.nih.gov/pubmed/32999229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5288-20
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items